GVK Bio Manni Kantipudi, CEO of GVK BIO, talks about the evolution of the company, which he took from USD 20 million to its current USD 120 million, its future, its strategic competitive advantages within the Indian CRO industry and his personal aspiration to reach the USD 200 million goal by 2021.…
Pharma DB Schenker’s Bart Coenen (BC) and Vincent Coolen (VC) explain the company’s Vision 2020 and talk about the benefits for pharma companies of outsourcing their supply chain. In 2013, DB Schenker announced the company’s Vision 2020. Can you please elaborate on this vision? BC: This strategy is about being an eco-pioneer,…
CRO Alan Ong, executive vice president for the Asia/Pacific region at INC Research, outlines the key challenges and opportunities that CROs face in the Malaysian clinical trial segment and describes INC’s role in raising the country’s profile as a destination for research. You represented another global CRO for almost 13…
Alliance of Bio-Box Outsourcing China Please introduce to our readers the general situation and driving force behind the creation of the Beijing Pharma and Biotech Center and its core mandate? Established in 1996, BPBC is an affiliated agency of the Beijing Municipal Science and Technology Commission and serves as a professional service organization for the…
Alliance of Bio-Box Outsourcing China Could you please give a brief introduction to the ABO and its history? ABO was established in 2005. The CRO business emerged in 2000 in China, and provided services for medicine factories; however, these CRO companies were small as individuals. As a result, they were gathered together and ABO was…
See our Cookie Privacy Policy Here